| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $542K | — | -21.2% |
| Cost of Revenue | $158K | — | -52.0% |
| Gross Profit | $384K | — | +7.0% |
| R&D Expense | $878K | — | +8.0% |
| SG&A Expense | $2.7M | — | -22.0% |
| Operating Income | -$4.0M | — | +16.5% |
| Pre-tax Income | -$3.2M | — | +14.2% |
| Income Tax | $0 | — | — |
| Net Income | -$3.2M | — | +14.2% |
| EPS (Basic) | -$0.16 | — | +11.1% |
| EPS (Diluted) | -$0.16 | — | +11.1% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $97.9M | -2.7% | -10.8% |
| Current Assets | $99.1M | -17.5% | -10.8% |
| Total Assets | $99.7M | -17.5% | -11.0% |
| Current Liabilities | $5.8M | -75.5% | -18.9% |
| Total Liabilities | $6.5M | -73.6% | -22.8% |
| Stockholders' Equity | $93.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$2.7M | — | +18.2% |
| Investing Cash Flow | $0 | — | — |
| Financing Cash Flow | $0 | — | -100.0% |
| -10.0% |